{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,19]],"date-time":"2026-09-19T21:45:16Z","timestamp":1789854316463,"version":"4.0.1"},"reference-count":50,"publisher":"Elsevier BV","issue":"9","license":[{"start":{"date-parts":[[2014,9,1]],"date-time":"2014-09-01T00:00:00Z","timestamp":1409529600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Journal of the American Academy of Child & Adolescent Psychiatry"],"published-print":{"date-parts":[[2014,9]]},"DOI":"10.1016\/j.jaac.2014.05.010","type":"journal-article","created":{"date-parts":[[2014,6,19]],"date-time":"2014-06-19T19:00:58Z","timestamp":1403204458000},"page":"960-970.e2","source":"Crossref","is-referenced-by-count":56,"title":["Growth in the Concurrent Use of Antipsychotics With Other Psychotropic Medications in Medicaid-Enrolled Children"],"prefix":"10.1016","volume":"53","author":[{"given":"Amanda R.","family":"Kreider","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meredith","family":"Matone","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christopher","family":"Bellonci","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Susan","family":"dosReis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chris","family":"Feudtner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuan-Shung","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Russell","family":"Localio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David M.","family":"Rubin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jaac.2014.05.010_bib1","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/j.ambp.2005.11.002","article-title":"Trends in prescribing of antipsychotic medications for US children","volume":"6","author":"Cooper","year":"2006","journal-title":"Ambul Pediatr"},{"key":"10.1016\/j.jaac.2014.05.010_bib2","doi-asserted-by":"crossref","first-page":"1836","DOI":"10.1111\/j.1475-6773.2012.01461.x","article-title":"The relationship between mental health diagnosis and treatment with second-generation antipsychotics over time: a national study of U.S. Medicaid-enrolled children","volume":"47","author":"Matone","year":"2012","journal-title":"Health Serv Res"},{"key":"10.1016\/j.jaac.2014.05.010_bib3","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1001\/archpsyc.63.6.679","article-title":"National trends in the outpatient treatment of children and adolescents with antipsychotic drugs","volume":"63","author":"Olfson","year":"2006","journal-title":"Arch Gen Psychiatry"},{"key":"10.1016\/j.jaac.2014.05.010_bib4","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1097\/01.chi.0000157543.74509.c8","article-title":"Trends in the use of typical and atypical antipsychotics in children and adolescents","volume":"44","author":"Patel","year":"2005","journal-title":"J\u00a0Am Acad Child Adolesc Psychiatry"},{"key":"10.1016\/j.jaac.2014.05.010_bib5","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1176\/appi.ps.201200081","article-title":"Antipsychotic use by Medicaid-insured youths: impact of eligibility and psychiatric diagnosis across a decade","volume":"64","author":"Zito","year":"2013","journal-title":"Psychiatr Serv"},{"key":"10.1016\/j.jaac.2014.05.010_bib6","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1001\/archpedi.157.1.17","article-title":"Psychotropic practice patterns for youth: a 10-year perspective","volume":"157","author":"Zito","year":"2003","journal-title":"Arch Pediatr Adolesc Med"},{"key":"10.1016\/j.jaac.2014.05.010_bib7","doi-asserted-by":"crossref","first-page":"1247","DOI":"10.1001\/archgenpsychiatry.2012.647","article-title":"National trends in the office-based treatment of children, adolescents, and adults with antipsychotics","volume":"69","author":"Olfson","year":"2012","journal-title":"Arch Gen Psychiatry"},{"key":"10.1016\/j.jaac.2014.05.010_bib8","doi-asserted-by":"crossref","first-page":"1135","DOI":"10.1542\/peds.2011-0855","article-title":"Antipsychotic medication use among children and risk of diabetes mellitus","volume":"128","author":"Andrade","year":"2011","journal-title":"Pediatrics"},{"key":"10.1016\/j.jaac.2014.05.010_bib9","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1080\/09540260801889179","article-title":"Monitoring and management of antipsychotic-related metabolic and endocrine adverse events in pediatric patients","volume":"20","author":"Correll","year":"2008","journal-title":"Int Rev Psychiatry"},{"key":"10.1016\/j.jaac.2014.05.010_bib10","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1097\/01.chi.0000220851.94392.30","article-title":"Endocrine and metabolic adverse effects of psychotropic medications in children and adolescents","volume":"45","author":"Correll","year":"2006","journal-title":"J\u00a0Am Acad Child Adolesc Psychiatry"},{"key":"10.1016\/j.jaac.2014.05.010_bib11","doi-asserted-by":"crossref","first-page":"1765","DOI":"10.1001\/jama.2009.1549","article-title":"Cardiometabolic risk of second-generation antipsychotic medications during first-time use in children and adolescents","volume":"302","author":"Correll","year":"2009","journal-title":"JAMA"},{"key":"10.1016\/j.jaac.2014.05.010_bib12","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1016\/j.eurpsy.2010.09.011","article-title":"Metabolic and endocrine adverse effects of second-generation antipsychotics in children and adolescents: a systematic review of randomized, placebo controlled trials and guidelines for clinical practice","volume":"26","author":"De Hert","year":"2011","journal-title":"Eur Psychiatry"},{"key":"10.1016\/j.jaac.2014.05.010_bib13","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1177\/070674370905401104","article-title":"Increased prevalence of obesity and glucose intolerance in youth treated with second-generation antipsychotic medications","volume":"54","author":"Panagiotopoulos","year":"2009","journal-title":"Canadian J Psychiatry"},{"key":"10.1016\/j.jaac.2014.05.010_bib14","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1097\/01.jcp.0000130558.86125.5b","article-title":"A\u00a0comparison of risperidone-induced weight gain across the age span","volume":"24","author":"Safer","year":"2004","journal-title":"J\u00a0Clin Psychopharmacol"},{"key":"10.1016\/j.jaac.2014.05.010_bib15","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1038\/sj.npp.1300327","article-title":"A\u00a0pilot study of risperidone, olanzapine, and haloperidol in psychotic youth: a double-blind, randomized, 8-week trial","volume":"29","author":"Sikich","year":"2004","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.jaac.2014.05.010_bib16","doi-asserted-by":"crossref","first-page":"1001","DOI":"10.1016\/j.jaac.2010.07.007","article-title":"National trends in child and adolescent psychotropic polypharmacy in office-based practice, 1996-2007","volume":"49","author":"Comer","year":"2010","journal-title":"J\u00a0Am Acad Child Adolesc Psychiatry"},{"key":"10.1016\/j.jaac.2014.05.010_bib17","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1089\/cap.2005.15.68","article-title":"Multiple psychotropic medication use for youths: a two-state comparison","volume":"15","author":"dosReis","year":"2005","journal-title":"J\u00a0Child Adolesc Psychopharmacol"},{"key":"10.1016\/j.jaac.2014.05.010_bib18","doi-asserted-by":"crossref","first-page":"e157","DOI":"10.1542\/peds.2007-0212","article-title":"Psychotropic medication patterns among youth in foster care","volume":"121","author":"Zito","year":"2008","journal-title":"Pediatrics"},{"key":"10.1016\/j.jaac.2014.05.010_bib19","doi-asserted-by":"crossref","first-page":"696","DOI":"10.1089\/cap.2005.15.696","article-title":"Adjunctive quetiapine for treatment-resistant adolescent major depressive disorder: a case series","volume":"15","author":"Pathak","year":"2005","journal-title":"J\u00a0Child Adolesc Psychopharmacol"},{"key":"10.1016\/j.jaac.2014.05.010_bib20","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1007\/s00787-006-0552-5","article-title":"Adjunctive olanzapine treatment in bipolar adolescents responding insufficiently to mood stabilizers. Four case reports","volume":"15","author":"Emiroglu","year":"2006","journal-title":"Eur Child Adolesc Psychiatry"},{"key":"10.1016\/j.jaac.2014.05.010_bib21","doi-asserted-by":"crossref","first-page":"1216","DOI":"10.1097\/00004583-200210000-00011","article-title":"A\u00a0double-blind, randomized, placebo-controlled study of quetiapine as adjunctive treatment for adolescent mania","volume":"41","author":"Delbello","year":"2002","journal-title":"J\u00a0Am Acad Child Adolesc Psychiatry"},{"key":"10.1016\/j.jaac.2014.05.010_bib22","doi-asserted-by":"crossref","first-page":"1448","DOI":"10.1097\/00004583-200112000-00016","article-title":"Adjunctive antipsychotic treatment of adolescents with bipolar psychosis","volume":"40","author":"Kafantaris","year":"2001","journal-title":"J\u00a0Am Acad Child Adolesc Psychiatry"},{"issue":"Suppl 1","key":"10.1016\/j.jaac.2014.05.010_bib23","doi-asserted-by":"crossref","first-page":"S103","DOI":"10.1016\/j.jad.2004.05.017","article-title":"Open-label prospective trial of risperidone in combination with lithium or divalproex sodium in pediatric mania","volume":"82","author":"Pavuluri","year":"2004","journal-title":"J\u00a0Affect Disord"},{"key":"10.1016\/j.jaac.2014.05.010_bib24","doi-asserted-by":"crossref","first-page":"2121","DOI":"10.1016\/j.ridd.2011.07.031","article-title":"Efficacy of atypical antipsychotic medication in the management of behaviour problems in children with intellectual disabilities and borderline intelligence: a systematic review","volume":"32","author":"Unwin","year":"2011","journal-title":"Res Dev Disabil"},{"key":"10.1016\/j.jaac.2014.05.010_bib25","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/j.jaac.2013.09.022","article-title":"What does risperidone add to parent training and stimulant for severe aggression in child attention-deficit\/hyperactivity disorder?","volume":"53","author":"Aman","year":"2014","journal-title":"J\u00a0Am Acad Child Adolesc Psychiatry"},{"key":"10.1016\/j.jaac.2014.05.010_bib26","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1007\/s11920-013-0355-6","article-title":"Antipsychotic and psychostimulant drug combination therapy in attention deficit\/hyperactivity and disruptive behavior disorders: a systematic review of efficacy and tolerability","volume":"15","author":"Linton","year":"2013","journal-title":"Curr Psychiatry Rep"},{"key":"10.1016\/j.jaac.2014.05.010_bib27","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1007\/BF02600099","article-title":"Polypharmacy: the cure becomes the disease","volume":"8","author":"Colley","year":"1993","journal-title":"J\u00a0Gen Intern Med"},{"key":"10.1016\/j.jaac.2014.05.010_bib28","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1089\/cap.2005.15.12","article-title":"Concomitant pharmacotherapy among youths treated in routine psychiatric practice","volume":"15","author":"Duffy","year":"2005","journal-title":"J\u00a0Child Adolesc Psychopharmacol"},{"key":"10.1016\/j.jaac.2014.05.010_bib29","first-page":"547","article-title":"Issues in polypharmacotherapy: focus on major depression","volume":"32","author":"Dufresne","year":"1996","journal-title":"Psychopharmacol Bull"},{"key":"10.1016\/j.jaac.2014.05.010_bib30","first-page":"797","article-title":"Escalating polypharmacy","volume":"99","author":"Gorard","year":"2006","journal-title":"Q\u00a0J Med"},{"key":"10.1016\/j.jaac.2014.05.010_bib31","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.1176\/appi.ps.52.8.1033","article-title":"Psychopharmacology: rational and irrational polypharmacy","volume":"52","author":"Kingsbury","year":"2001","journal-title":"Psychiatr Serv"},{"key":"10.1016\/j.jaac.2014.05.010_bib32","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1046\/j.1365-2125.1999.00943.x","article-title":"A\u00a0prospective study of adverse drug reactions in hospitalized children","volume":"47","author":"Mart\u00ednez-Mir","year":"1999","journal-title":"Br J Clin Pharmacol"},{"key":"10.1016\/j.jaac.2014.05.010_bib33","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1176\/appi.ajp.160.3.438","article-title":"Concomitant psychotropic medication for youths","volume":"160","author":"Safer","year":"2003","journal-title":"Am J Psychiatry"},{"key":"10.1016\/j.jaac.2014.05.010_bib34","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1017\/S1461145704004146","article-title":"Focus on antipsychotic polypharmacy: evidence-based prescribing or prescribing-based evidence?","volume":"7","author":"Stahl","year":"2004","journal-title":"Int J Neuropsychopharmacol"},{"key":"10.1016\/j.jaac.2014.05.010_bib35","doi-asserted-by":"crossref","first-page":"965","DOI":"10.1111\/j.1651-2227.1999.tb00191.x","article-title":"Adverse drug reactions to unlicensed and off-label drugs on paediatric wards: a prospective study","volume":"88","author":"Turner","year":"1999","journal-title":"Acta Paediatr"},{"key":"10.1016\/j.jaac.2014.05.010_bib36","doi-asserted-by":"crossref","first-page":"w770","DOI":"10.1377\/hlthaff.28.5.w770","article-title":"Broadened use of atypical antipsychotics: safety, effectiveness, and policy challenges","volume":"28","author":"Crystal","year":"2009","journal-title":"Health Aff"},{"key":"10.1016\/j.jaac.2014.05.010_bib37","series-title":"The composition of children enrolled in Medicaid and CHIP: variation over time and by race and ethnicity","author":"Coyer","year":"2013"},{"key":"10.1016\/j.jaac.2014.05.010_bib38","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1089\/cap.2005.15.97","article-title":"Psychotropic medication use in a national probability sample of children in the child welfare system","volume":"15","author":"Raghavan","year":"2005","journal-title":"J\u00a0Child Adolesc Psychopharmacol"},{"key":"10.1016\/j.jaac.2014.05.010_bib39","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1176\/appi.ps.56.2.157","article-title":"Effect of Medicaid eligibility category on racial disparities in the use of psychotropic medications among youths","volume":"56","author":"Zito","year":"2005","journal-title":"Psychiatr Serv"},{"key":"10.1016\/j.jaac.2014.05.010_bib40","doi-asserted-by":"crossref","first-page":"1094","DOI":"10.2105\/AJPH.91.7.1094","article-title":"Mental health services for youths in foster care and disabled youths","volume":"91","author":"dosReis","year":"2001","journal-title":"Am J Public Health"},{"key":"10.1016\/j.jaac.2014.05.010_bib41","series-title":"Assessing the usability of encounter data for enrollees in comprehensive managed care across MAX 2007\u20132009","author":"Byrd","year":"2012"},{"key":"10.1016\/j.jaac.2014.05.010_bib42","series-title":"The availability and usability of behavioral health organization encounter data in MAX 2009","author":"Nysenbaum","year":"2013"},{"key":"10.1016\/j.jaac.2014.05.010_bib43","doi-asserted-by":"crossref","first-page":"652","DOI":"10.1111\/j.0006-341X.1999.00652.x","article-title":"Predictive margins with survey data","volume":"55","author":"Graubard","year":"1999","journal-title":"Biometrics"},{"key":"10.1016\/j.jaac.2014.05.010_bib44","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1186\/1471-244X-13-198","article-title":"Prescribing trends of antipsychotics in youth receiving income assistance: results from a retrospective population database study","volume":"13","author":"Murphy","year":"2013","journal-title":"BMC Psychiatry"},{"key":"10.1016\/j.jaac.2014.05.010_bib45","doi-asserted-by":"crossref","first-page":"e1459","DOI":"10.1542\/peds.2010-2970","article-title":"Antipsychotic treatment among youth in foster care","volume":"128","author":"dosReis","year":"2011","journal-title":"Pediatrics"},{"key":"10.1016\/j.jaac.2014.05.010_bib46","doi-asserted-by":"crossref","first-page":"788","DOI":"10.1176\/appi.ps.61.8.788","article-title":"Mental health care for children with disruptive behavior problems: a view inside therapists' offices","volume":"61","author":"Garland","year":"2010","journal-title":"Psychiatr Serv"},{"key":"10.1016\/j.jaac.2014.05.010_bib47","unstructured":"Findling RL, Drury SS, Jensen PS, et\u00a0al. Practice parameter for the use of atypical antipsychotic medications in children and adolescents. J Am Acad Child Adolesc Psychiatry. In press."},{"key":"10.1016\/j.jaac.2014.05.010_bib48","doi-asserted-by":"crossref","first-page":"1067","DOI":"10.1001\/jamapsychiatry.2013.2053","article-title":"Antipsychotics and the risk of type 2 diabetes mellitus in children and youth","volume":"70","author":"Bobo","year":"2013","journal-title":"JAMA Psychiatry"},{"key":"10.1016\/j.jaac.2014.05.010_bib49","doi-asserted-by":"crossref","first-page":"267","DOI":"10.4088\/JCP.v65n0219","article-title":"Consensus development conference on antipsychotic drugs and obesity and diabetes","volume":"65","year":"2004","journal-title":"J\u00a0Clin Psychiatry"},{"key":"10.1016\/j.jaac.2014.05.010_bib50","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1001\/archpediatrics.2010.48","article-title":"Metabolic screening in children receiving antipsychotic drug treatment","volume":"164","author":"Morrato","year":"2010","journal-title":"Arch Pediatr Adolesc Med"}],"container-title":["Journal of the American Academy of Child & Adolescent Psychiatry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0890856714003980?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0890856714003980?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,8,11]],"date-time":"2019-08-11T18:57:25Z","timestamp":1565549845000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0890856714003980"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,9]]},"references-count":50,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2014,9]]}},"alternative-id":["S0890856714003980"],"URL":"https:\/\/doi.org\/10.1016\/j.jaac.2014.05.010","relation":{},"ISSN":["0890-8567"],"issn-type":[{"value":"0890-8567","type":"print"}],"subject":[],"published":{"date-parts":[[2014,9]]}}}